Economic Analysis of Alternative Strategies for Detection of ALK Rearrangements in Non Small Cell Lung Cancer

Author： Doshi Shivang   Ray David   Stein Karen   Zhang Jie   Koduru Prasad   Fogt Franz   Wellman Axel   Wat Ricky   Mathews Charles  

Publisher： MDPI

E-ISSN： 2075-4418|6|1|4-4

ISSN： 2075-4418

Source： Diagnostics, Vol.6, Iss.1, 2016-01, pp. : 4-4

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Therapies in Non-Small Cell Lung Cancer—Beyond EGFR and ALK

By Rothschild Sacha I.  

Cancers, Vol. 7, Iss. 2, 2015-05 ,pp. : 930-949

MDPI

Access to resources Recommend Favorite

Biochip-Based Detection of KRAS Mutation in Non-Small Cell Lung Cancer

By Kriegshäuser Gernot   Fabjani Gerhild   Ziegler Barbara   Zöchbauer-Müller Sabine   End Adelheid   Zeillinger Robert  

International Journal of Molecular Sciences, Vol. 12, Iss. 12, 2011-11 ,pp. : 8530-8538

MDPI

Access to resources Recommend Favorite

Mutations in EMT-Related Genes in ALK Positive Crizotinib Resistant Non-Small Cell Lung Cancers

By Wei Jiacong   van der Wekken Anthonie J.   Saber Ali   Terpstra Miente M.   Schuuring Ed   Timens Wim   Hiltermann T. Jeroen N.   Groen Harry J. M.   van den Berg Anke   Kok Klaas  

Cancers, Vol. 10, Iss. 1, 2018-01 ,pp. : 10-10

MDPI

Access to resources Recommend Favorite

Proteomic Analysis Identified DJ-1 as a Cisplatin Resistant Marker in Non-Small Cell Lung Cancer

By Zeng Hua-Zong   Qu Yi-Qing   Zhang Wen-Jun   Xiu Bing   Deng An-Mei   Liang Ai-Bin  

International Journal of Molecular Sciences, Vol. 12, Iss. 6, 2011-06 ,pp. : 3489-3499

MDPI

Access to resources Recommend Favorite

The Role of STAT3 in Non-Small Cell Lung Cancer

By Harada Daijiro   Takigawa Nagio   Kiura Katsuyuki  

Cancers, Vol. 6, Iss. 2, 2014-03 ,pp. : 708-722

MDPI

Access to resources Recommend Favorite